Filed: 11/14/2025ACC: 0001937964-25-000008
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 48 equity positions with a total reported market value of $630.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
48
Positions
$630.89M
Total AUM (reported)
10.69M
Total Shares
Allocation by class
COM$244.83M38.8%
COM PAR $.01$163.05M25.8%
SPONSORED ADR$74.83M11.9%
SPONSORED ADS$62.82M10.0%
SHS$38.46M6.1%
ULTRA GOLD$24.75M3.9%
COM NEW$12.95M2.1%
Portfolio Concentration
Top 3$266.25M42.2%
4–10$194.21M30.8%
11–25$134.40M21.3%
Rest$36.03M5.7%
Top 3 weight
42.2%
Top 10 weight
73.0%
Voting Authority Distribution
Total shares with voting rights: 10.69M
Sole
Full voting authority
10.69M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole48
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings48
Rows:
INSMED INC
SOLEShares1.13M
TypeSH
Market value$163.05M
25.84%
Sole
1.13M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares78.31K
TypeSH
Market value$57.76M
9.16%
Sole
78.31K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares672.18K
TypeSH
Market value$45.44M
7.20%
Sole
672.18K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares379K
TypeSH
Market value$40.44M
6.41%
Sole
379K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares658.84K
TypeSH
Market value$38.46M
6.10%
Sole
658.84K
Shared
0.00
None
0.00
MERUS N V
SOLEShares296.75K
TypeSH
Market value$27.94M
4.43%
Sole
296.75K
Shared
0.00
None
0.00
PROSHARES TR II
SOLEShares537.37K
TypeSH
Market value$24.75M
3.92%
Sole
537.37K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares28.70K
TypeSH
Market value$21.90M
3.47%
Sole
28.70K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares55.10K
TypeSH
Market value$21.58M
3.42%
Sole
55.10K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares225.45K
TypeSH
Market value$19.14M
3.03%
Sole
225.45K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$18.30M
2.90%
Sole
2M
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares183.20K
TypeSH
Market value$17.89M
2.84%
Sole
183.20K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares34.57K
TypeSH
Market value$15.76M
2.50%
Sole
34.57K
Shared
0.00
None
0.00
QUEST DIAGNOSTICS INC
SOLEShares81.72K
TypeSH
Market value$15.57M
2.47%
Sole
81.72K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$14.63M
2.32%
Sole
190.75K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares628.37K
TypeSH
Market value$8.95M
1.42%
Sole
628.37K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares214.50K
TypeSH
Market value$6.45M
1.02%
Sole
214.50K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares10.67K
TypeSH
Market value$6.00M
0.95%
Sole
10.67K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares194.84K
TypeSH
Market value$5.54M
0.88%
Sole
194.84K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares104.19K
TypeSH
Market value$4.87M
0.77%
Sole
104.19K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares110.10K
TypeSH
Market value$4.80M
0.76%
Sole
110.10K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares108.72K
TypeSH
Market value$4.28M
0.68%
Sole
108.72K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares60.18K
TypeSH
Market value$3.94M
0.62%
Sole
60.18K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares146.18K
TypeSH
Market value$3.84M
0.61%
Sole
146.18K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares96.28K
TypeSH
Market value$3.59M
0.57%
Sole
96.28K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INSMED INCSOLE | COM PAR $.01 | 1.13M | SH | $163.05M 25.84% | 1.13M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 78.31K | SH | $57.76M 9.16% | 78.31K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 672.18K | SH | $45.44M 7.20% | 672.18K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 379K | SH | $40.44M 6.41% | 379K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 658.84K | SH | $38.46M 6.10% | 658.84K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 296.75K | SH | $27.94M 4.43% | 296.75K | 0.00 | 0.00 |
PROSHARES TR IISOLE | ULTRA GOLD | 537.37K | SH | $24.75M 3.92% | 537.37K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 28.70K | SH | $21.90M 3.47% | 28.70K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 55.10K | SH | $21.58M 3.42% | 55.10K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 225.45K | SH | $19.14M 3.03% | 225.45K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2M | SH | $18.30M 2.90% | 2M | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 183.20K | SH | $17.89M 2.84% | 183.20K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 34.57K | SH | $15.76M 2.50% | 34.57K | 0.00 | 0.00 |
QUEST DIAGNOSTICS INCSOLE | COM | 81.72K | SH | $15.57M 2.47% | 81.72K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $14.63M 2.32% | 190.75K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 628.37K | SH | $8.95M 1.42% | 628.37K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 214.50K | SH | $6.45M 1.02% | 214.50K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 10.67K | SH | $6.00M 0.95% | 10.67K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 194.84K | SH | $5.54M 0.88% | 194.84K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 104.19K | SH | $4.87M 0.77% | 104.19K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 110.10K | SH | $4.80M 0.76% | 110.10K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 108.72K | SH | $4.28M 0.68% | 108.72K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 60.18K | SH | $3.94M 0.62% | 60.18K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 146.18K | SH | $3.84M 0.61% | 146.18K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 96.28K | SH | $3.59M 0.57% | 96.28K | 0.00 | 0.00 |
Page 1 of 2